Incorporating Weight Management and Physical Activity Throughout the Cancer Care Continuum: Proceedings of a Workshop

Review
Washington (DC): National Academies Press (US); 2018 Jan 12.
The National Academies Collection: Reports funded by National Institutes of Health.

Excerpt

The National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine held a public workshop, Incorporating Weight Management and Physical Activity Throughout the Cancer Care Continuum, on February 13 and 14, 2017, in Washington, DC. The purpose of this workshop was to highlight the current evidence base, gaps in knowledge, and research needs on the associations among obesity, physical activity, weight management, and health outcomes for cancer survivors, as well as to examine the effectiveness of interventions for promoting physical activity and weight management among people living with or beyond cancer. Workshop sessions also reviewed the opportunities and challenges for providing weight management and physical activity interventions to cancer survivors. This publication summarizes the presentations and discussions from the workshop.

Publication types

  • Review

Grants and funding

This activity was supported by Contract No. 200-2011-38807 (Task Order No. 0051) and Contract No. HHSN263201200074I (Task Order No. HHSN26300052) with the Centers for Disease Control and Prevention and the National Cancer Institute/National Institutes of Health, respectively, and by the American Association for Cancer Research, American Cancer Society, American College of Lifestyle Medicine, American College of Radiology, American College of Sports Medicine, American Council on Exercise, American Society of Clinical Oncology, American Society of Hematology, Association of American Cancer Institutes, AstraZeneca, Bristol-Myers Squibb, Cancer Support Community, CEO Roundtable on Cancer, Dana-Farber Cancer Institute, Flatiron Health, Helsinn Therapeutics (U.S.), Inc., LIVESTRONG Foundation, Medical Fitness Association, Merck, National Comprehensive Cancer Network, Novartis Oncology, Oncology Nursing Society, Penn State Cancer Institute, Pfizer Inc., and The University of Texas MD Anderson Cancer Center. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.